Tue, Sep 2, 2014, 9:25 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

  • rx7171 rx7171 Jun 24, 2013 5:06 PM Flag

    Uplisting requirements

    NVIV currently meets the NYSE Amex $2 and $3 share price requirement for uplisting.
    In 2012 the NASDAQ Capital Market $4 rule was changed to $3 plus other requirements that NVIV currently meets. So no impedement currently to stop uplisting to either.

    SECURITIES AND EXCHANGE COMMISSION (Release No. 34-66830; File No. SR-NASDAQ-2012-002)
    April 18, 2012
    Self-Regulatory Organizations; The NASDAQ Stock Market LLC; Notice of Filing of Amendment No. 1 and Order Granting Accelerated Approval to Proposed Rule Change, as Modified by Amendment No. 1, to Adopt an Alternative to the $4 Per Share Initial Listing Bid Price Requirement for the Nasdaq Capital Market of Either $2 Closing Price Per Share or $3 Closing Price Per Share, If Certain Other Listing Requirements are Met.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NVIV
0.60-0.02(-3.23%)Sep 2 3:57 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.